Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shaowei Qiu

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Experimental Hematology & Oncology|September 17, 2021
Efficacy of combination of venetoclax with azacitidine or chemotherapy in refractory/relapse acute leukemias of ambiguous lineage, not otherwise specifiedKaiqi Liu, Yan Li, Shaowei Qiu, et al.
Experimental Hematology|February 1, 2021
Optimized clinical application of minimal residual disease in acute myeloid leukemia with RUNX1-RUNX1T1Hui Wei, Xueou Liu, Ying Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 8, 2020
Randomized Trial of Intermediate-dose Cytarabine in Induction and Consolidation Therapy in Adults with Acute Myeloid LeukemiaHui Wei, Ying Wang, Robert Peter Gale, et al.
Leukemia|September 5, 2025
Correction: Olverembatinib combined with venetoclax and reduced-intensity chemotherapy for adult newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a single-center, single-arm, phase 2 trialXiaoyuan Gong, Wenbing Liu, Yuntao Liu, et al.
Haematologica|March 19, 2026
The prognostic role of myeloid-related gene mutations in adult acute lymphoblastic leukemiaWenting Wang, Jiayuan Chen, Yan Li, et al.
Leukemia|November 1, 2024
The dynamic evolution of lineage switch under CD19 CAR-T treatment in non-KMT2A rearranged B-ALL patientsShaowei Qiu, Yihan Mei, Runxia Gu, et al.
Cell|March 10, 2026
Ferritin aggregation cell engager for CAR T avidity engineering against refractory leukemiasFeng Li, Yuxing Hu, Yan Wang, et al.
British Journal of Haematology|March 11, 2022
The prognostic factors in acute myeloid leukaemia with double-mutated CCAAT/enhancer-binding protein alpha (CEBPAdm)Hui Wei, Chunlin Zhou, Bingcheng Liu, et al.
Blood|May 16, 2023
Metabolic adaptation to tyrosine kinase inhibition in leukemia stem cellsShaowei Qiu, Vipul Sheth, Chengcheng Yan, et al.
Journal of the American Heart Association|September 26, 2023
Altered Peripheral Blood Gene Expression in Childhood Cancer Survivors With Anthracycline-Induced Cardiomyopathy - A COG-ALTE03N1 ReportPurnima Singh, Disheet A Shah, Mariam Jouni, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Experimental Hematology & Oncology|September 17, 2021
Efficacy of combination of venetoclax with azacitidine or chemotherapy in refractory/relapse acute leukemias of ambiguous lineage, not otherwise specifiedKaiqi Liu, Yan Li, Shaowei Qiu, et al.
Experimental Hematology|February 1, 2021
Optimized clinical application of minimal residual disease in acute myeloid leukemia with RUNX1-RUNX1T1Hui Wei, Xueou Liu, Ying Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 8, 2020
Randomized Trial of Intermediate-dose Cytarabine in Induction and Consolidation Therapy in Adults with Acute Myeloid LeukemiaHui Wei, Ying Wang, Robert Peter Gale, et al.
Leukemia|September 5, 2025
Correction: Olverembatinib combined with venetoclax and reduced-intensity chemotherapy for adult newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a single-center, single-arm, phase 2 trialXiaoyuan Gong, Wenbing Liu, Yuntao Liu, et al.
Haematologica|March 19, 2026
The prognostic role of myeloid-related gene mutations in adult acute lymphoblastic leukemiaWenting Wang, Jiayuan Chen, Yan Li, et al.
Leukemia|November 1, 2024
The dynamic evolution of lineage switch under CD19 CAR-T treatment in non-KMT2A rearranged B-ALL patientsShaowei Qiu, Yihan Mei, Runxia Gu, et al.
Cell|March 10, 2026
Ferritin aggregation cell engager for CAR T avidity engineering against refractory leukemiasFeng Li, Yuxing Hu, Yan Wang, et al.
British Journal of Haematology|March 11, 2022
The prognostic factors in acute myeloid leukaemia with double-mutated CCAAT/enhancer-binding protein alpha (CEBPAdm)Hui Wei, Chunlin Zhou, Bingcheng Liu, et al.
Blood|May 16, 2023
Metabolic adaptation to tyrosine kinase inhibition in leukemia stem cellsShaowei Qiu, Vipul Sheth, Chengcheng Yan, et al.
Journal of the American Heart Association|September 26, 2023
Altered Peripheral Blood Gene Expression in Childhood Cancer Survivors With Anthracycline-Induced Cardiomyopathy - A COG-ALTE03N1 ReportPurnima Singh, Disheet A Shah, Mariam Jouni, et al.
Pageof 7